Long-term results of a phase II study of hypofractionated proton therapy for prostate cancer: moderate versus extreme hypofractionation

BACKGROUND: We performed a prospective phase II study to compare acute toxicity among five different hypofractionated schedules using proton therapy. This study was an exploratory analysis to investigate the secondary end-point of biochemical failure-free survival (BCFFS) of patients with long-term...

Descripción completa

Detalles Bibliográficos
Autores principales: Ha, Boram, Cho, Kwan Ho, Lee, Kang Hyun, Joung, Jae Young, Kim, Yeon-Joo, Lee, Sung Uk, Kim, Hyunjung, Suh, Yang-Gun, Moon, Sung Ho, Lim, Young Kyung, Jeong, Jong Hwi, Kim, Haksoo, Park, Weon Seo, Kim, Sun Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327508/
https://www.ncbi.nlm.nih.gov/pubmed/30630500
http://dx.doi.org/10.1186/s13014-019-1210-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327508/
https://www.ncbi.nlm.nih.gov/pubmed/30630500
http://dx.doi.org/10.1186/s13014-019-1210-7

Ejemplares similares